Advertisement

Organisation › Details
Just – Evotec Biologics Inc.
Just - Evotec Biologics, wholly owned by Evotec SE, is a unique platform company that integrates the design, engineering, development, and manufacture of biologics. With deep experience in the fields of protein, process and manufacturing sciences, the Just team came together to solve the scientific and technical hurdles that block access to life-changing protein therapeutics; from the design of therapeutic molecules to the design of the manufacturing plants used to produce them. Our focus is to create access and value for a global market through scientific and technological innovation. *
![]() |
Start | 2019-07-03 renamed date ca |
Group | Evotec (Group) | |
Predecessor | Just Biotherapeutics Inc. (Just – Evotec Biologics) (Just.Bio, US) | |
![]() |
Industry | biopharmaceutical |
Industry 2 | drug development services | |
![]() |
Person | Thomas, James N. (Jim) (Evotec 201905– EVP Global Head Biotherapeutics + President US Operations before CEO of Just.Bio) |
![]() |
Region | Seattle, WA |
Country | United States (USA) | |
Street | 401 Terry Avenue North South Lake Union | |
City | 98109 Seattle, WA | |
Tel | +1-206-651-5094 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | D: 101 to 500 (2021-08-11) |
Currency | USD | |
Annual sales | 20,000,000 (revenues (2018) 2018-12-31) | |
* Document for »About Section«: Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru. | ||
Record changed: 2024-01-03 |
Advertisement

More documents for Evotec (Group)
- [1] Evotec SE. (11/29/24). "Press Release: Evotec Announces Change in Management Board. Dr Craig Johnstone Steps Down as Chief Operating Officer Effective 31 December 2024". Hamburg....
- [2] Halozyme Therapeutics, Inc.. (11/22/24). "Press Release: Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions". San Diego, CA....
- [3] Halozyme Therapeutics, Inc.. (11/18/24). "Press Release: Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec". San Diego, CA....
- [4] Halozyme Therapeutics, Inc.. (11/14/24). "Press Release: Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction". San Diego, CA....
- [5] Evotec SE. (9/3/24). "Press Release: Evotec Announces Change in Management Board. Dr Matthias Evers Steps Down as Chief Business Officer Effective 01 October 2024". Hamburg....
- [6] Evotec SE. (7/8/24). "Press Release: Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz". Hamburg & Seattle, WA....
- [7] Evotec SE. (6/25/24). "Press Release: Just – Evotec Biologics Selected by U.S. Department of Defense for Manufacturing Optimization Program". Hamburg....
- [8] Evotec SE. (6/12/24). "Press Release: Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb". Hamburg....
- [9] Evotec SE. (6/10/24). "Press Release: Results of the Annual General Meeting 2024". Hamburg....
- [10] Evotec SE. (6/3/24). "Press Release: Evotec and Qiagen Enter Software Collaboration for Enhanced Multi-omics Data Insights". Hamburg & Venlo....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top